QID 241940

Date Published: 2023-08-09

QID 241940: Red Hat Update for iperf3 (RHSA-2023:4570)

Iperf is a tool which can measure maximum tcp bandwidth and tune various parameters and udp characteristics.
Iperf reports bandwidth, delay jitter, and data-gram loss...Security Fix(es):

    iperf3: memory allocation hazard and crash (cve-2023-38403).
Affected Products:
    Red Hat enterprise linux for x86_64 8 x86_64.
    Red hat enterprise linux for x86_64 - extended update support 8.8 x86_64.
    Red hat enterprise linux for ibm z systems 8 s390x.
    Red hat enterprise linux for ibm z systems - extended update support 8.8 s390x.
    Red hat enterprise linux for power, little endian 8 ppc64le.
    Red hat enterprise linux for power, little endian - extended update support 8.8 ppc64le.
    Red hat enterprise linux server - tus 8.8 x86_64.
    Red hat enterprise linux for arm 64 8 aarch64.
    Red hat enterprise linux for arm 64 - extended update support 8.8 aarch64.
    Red hat enterprise linux server for power le - update services for sap solutions 8.8 ppc64le.
    Red hat enterprise linux for x86_64 - update services for sap solutions 8.8 x86_64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as High - 7.5 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2023:4570 for updates and patch information.
    Vendor References

    CVEs related to QID 241940

    CVE-2023-38403 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2023:4570 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2023:4570
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].